Inspection Record

Stanley Specialty Pharmacy Compounding and Wellness Center — FDA 483 Findings

US FDAInspected 2017-09-19Published 2024-01-17 3 findingsAseptic processing and sterility assuranceOther quality system

Inspectors Seneca Toms · Bonita ChesterThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Aseptic processing and sterility assurance

Disinfecting agents and cleaning pads or wipes used in the ISO 5 aseptic processing areas are not sterile.

2Aseptic processing and sterility assurance

Environmental monitoring was not performed in your aseptic processing areas.

3Other quality system

There is insufficient data to support the percentage of preservative used to ensure anti-microbial effectiveness in multi-dose stock solutions which are used to formulate finished product.

About this record

Extracted automatically from the document US FDA published on 2024-01-17. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Stanley Specialty Pharmacy Compounding and Wellness Center findings history — including this company's other documents US FDA documents, 2024 Go to Findings search